Zambrowicz, B., Freiman, J., Brown, P. M., Frazier, K. S., Turnage, A., Bronner, J., . . . Powell, D. R. (2012). LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Nature Publishing Group.
Citação norma ChicagoZambrowicz, B., et al. LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Nature Publishing Group, 2012.
Citação norma MLAZambrowicz, B., et al. LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial. Nature Publishing Group, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.